SCIENCE · CONTEXT · COMMUNITY
A focused library on KDM6B, Stolerman syndrome and related research. Connecting clinical findings, experimental models and questions that matter to families and research teams.
3 published articles
A KDM6B diagnosis connects a change in a gene to questions about development, communication and learning. Understanding that connection starts with three different levels of evidence: what the protein does, what researchers observe in groups of people, and what is known about a particular person's variant.
A patient's genetic report identifies a variant. A cell model can help researchers investigate what that variant does. Patient-derived induced pluripotent stem cells, or iPSCs, provide one route between those two kinds of information. Their value depends on the question and the quality of the experiment—not simply on having a line in a freezer.
The most useful KDM6B update is not a list of every new mention of the gene. It is an explanation of what a study changes, what it leaves unresolved, and which experiment could test the next link. This focused review considers three complementary lines of evidence available on 14 November 2026: human phenotype, postnatal myelination in a mouse model, and a candidate relationship with cerebral folate deficiency.
The gene, variants, epigenetics and neurodevelopment.
Important publications, models and open scientific questions.
Documented milestones and shareable findings from the Alliance.
Registries, family participation and the international community.
We prioritise original studies and clearly distinguish evidence from people, animals and cells. Preprints are labelled, and related findings in other genes are not presented as evidence for KDM6B. A meaningful development may warrant updating an existing article.
Our Editorial Standards